Bansisons Tea Industries Ltd
₹ 11.4
4.99%
15 Jun
- close price
About
Incorporated in 1987, Bansisons Tea Industries Ltd produces tea, and leases tea garden[1]
Key Points
- Market Cap ₹ 7.20 Cr.
- Current Price ₹ 11.4
- High / Low ₹ 16.6 / 5.88
- Stock P/E
- Book Value ₹ 0.98
- Dividend Yield 0.00 %
- ROCE -162 %
- ROE -162 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 11.6 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -7.79% over past five years.
- Promoter holding is low: 23.2%
- Company has a low return on equity of -36.6% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.43 | 1.05 | 1.50 | 1.73 | 1.72 | 0.15 | 0.15 | 0.15 | 0.15 | -0.00 | -0.00 | 0.10 | |
| 1.35 | 1.00 | 1.41 | 1.73 | 1.82 | 0.15 | 0.09 | 0.17 | 0.11 | 0.14 | 0.08 | 5.50 | |
| Operating Profit | 0.08 | 0.05 | 0.09 | -0.00 | -0.10 | -0.00 | 0.06 | -0.02 | 0.04 | -0.14 | -0.08 | -5.40 |
| OPM % | 5.59% | 4.76% | 6.00% | -0.00% | -5.81% | -0.00% | 40.00% | -13.33% | 26.67% | -5,400.00% | ||
| 1.05 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.05 | 0.04 | 0.01 | -0.00 | 0.05 | 0.06 | |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Depreciation | 0.06 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Profit before tax | 1.07 | 0.01 | 0.05 | -0.03 | -0.12 | -0.02 | 0.09 | -0.00 | 0.03 | -0.16 | -0.06 | -5.37 |
| Tax % | 0.93% | 100.00% | 60.00% | 33.33% | -0.00% | -0.00% | 11.11% | -0.00% | 66.67% | -0.00% | -0.00% | -0.00% |
| 1.06 | 0.01 | 0.02 | -0.04 | -0.13 | -0.02 | 0.08 | -0.00 | 0.01 | -0.16 | -0.06 | -5.37 | |
| EPS in Rs | 1.67 | 0.02 | 0.03 | -0.06 | -0.21 | -0.03 | 0.13 | -0.00 | 0.02 | -0.25 | -0.09 | -8.48 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -8% |
| 3 Years: | -13% |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -8850% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 16% |
| 1 Year: | 103% |
| Return on Equity | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -20% |
| 3 Years: | -37% |
| Last Year: | -162% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.20 | 6.20 | 6.20 | 6.20 | 6.20 | 6.20 | 6.20 | 6.20 | 6.20 | 6.20 | 6.33 | 6.33 |
| Reserves | -0.06 | -0.04 | -0.02 | -0.06 | -0.19 | -0.20 | -0.13 | -0.12 | -0.11 | -0.27 | -0.33 | -5.71 |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| 0.10 | 0.22 | 0.42 | 0.38 | 0.18 | 0.08 | 0.15 | 0.13 | 0.16 | 0.19 | 0.18 | 0.87 | |
| Total Liabilities | 6.24 | 6.38 | 6.60 | 6.52 | 6.19 | 6.08 | 6.22 | 6.21 | 6.25 | 6.12 | 6.18 | 1.49 |
| 4.69 | 4.83 | 5.01 | 4.98 | 5.03 | 5.13 | 5.11 | 5.10 | 5.08 | 5.06 | 4.93 | 0.74 | |
| CWIP | 0.09 | 0.20 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| 1.46 | 1.35 | 1.59 | 1.54 | 1.16 | 0.95 | 1.11 | 1.11 | 1.17 | 1.06 | 1.25 | 0.75 | |
| Total Assets | 6.24 | 6.38 | 6.60 | 6.52 | 6.19 | 6.08 | 6.22 | 6.21 | 6.25 | 6.12 | 6.18 | 1.49 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.02 | 0.25 | -0.27 | -0.04 | -0.09 | 0.01 | -0.02 | -0.06 | 0.14 | -0.14 | -0.28 | -3.79 | |
| -0.39 | -0.29 | -0.02 | -0.00 | -0.07 | -0.12 | 0.05 | 0.03 | 0.01 | -0.00 | 0.18 | 3.85 | |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.28 | -0.15 | |
| Net Cash Flow | 0.63 | -0.04 | -0.28 | -0.04 | -0.16 | -0.11 | 0.03 | -0.03 | 0.14 | -0.14 | 0.18 | -0.09 |
| Free Cash Flow | -0.72 | -0.10 | -0.38 | -0.04 | -0.16 | -0.11 | -0.02 | -0.07 | 0.14 | -0.14 | -0.18 | -0.07 |
| CFO/OP | 1,288% | 520% | -267% | 90% | -17% | 300% | 400% | 100% | 350% | 70% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 117.41 | 184.24 | 80.30 | 50.64 | 31.83 | 170.33 | 146.00 | 194.67 | 340.67 | 36.50 | ||
| Inventory Days | -0.00 | -0.00 | 16.85 | 64.41 | -0.00 | |||||||
| Days Payable | 168.46 | 257.65 | ||||||||||
| Cash Conversion Cycle | 117.41 | 184.24 | -71.32 | -142.60 | 31.83 | 170.33 | 146.00 | 194.67 | 340.67 | 36.50 | ||
| Working Capital Days | 91.89 | 107.76 | -17.03 | -8.44 | -6.37 | -48.67 | 121.67 | 146.00 | 219.00 | -1,095.00 | ||
| ROCE % | 0.88% | 0.16% | 0.81% | -0.49% | -1.98% | -0.33% | 1.49% | -0.00% | 0.49% | -2.66% | -1.01% | -162.24% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Green Leaf Production Kgs |
|
||||||||||
| Black Tea Production Kgs |
|||||||||||
| Tea Area Hectares |
|||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
- Reg. 34 (1) Annual Report. 5 Jun
-
Annual Report 2025-2026
1 Jun - AGM on 25 June 2026; proposes 85.71% capital reduction and appoints Anilkumar Amreliya as MD.
-
AGM Notice
1 Jun - AGM on June 25, 2026 to approve 85.71% capital reduction and appoint Anilkumar Amreliya as MD.
-
Reg 32
30 May - No deviation in use of Rs.13.24 lakh preferential issue proceeds raised on 9 June 2025 for working capital.
-
Revised Outcome For Annual General Meeting Notice
26 May - Board approved revised 39th AGM notice; AGM on 25 June 2026, with e-voting dates updated.
Annual reports
-
Financial Year 2026
from bse
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Overview:[1]
The Company is engaged in the business of Pharmaceuticals, Real Estate & Tea Estate.